Cargando…

Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria

BACKGROUND: Anaphylaxis is a life-threatening systemic allergic reaction. Omalizumab (OMA) is an established treatment in chronic urticaria (CU), but experience in anaphylaxis is limited. OBJECTIVES: The objective was to evaluate the efficacy and safety of OMA on anaphylaxis in patients with CU who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Xiaoting, Liu, Bo, Yu, Miao, Liao, Shuanglu, Luan, Tingting, Li, Changling, Zhao, Zuotao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Clinical Allergy − Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932819/ https://www.ncbi.nlm.nih.gov/pubmed/36327946 http://dx.doi.org/10.1159/000527158

Ejemplares similares

Efficacy and safety of omalizumab therapy in urticaria vasculitis
por: Petrelli, Fiorella, et al.
Publicado: (2022)

Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous Urticaria
por: Ridge, Katie, et al.
Publicado: (2021)

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
por: García-Gómez, Elizabeth, et al.
Publicado: (2022)

269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012)

Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management
por: Ensina, Luis Felipe, et al.
Publicado: (2022)

Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
por: Mobayed, Hassan, et al.
Publicado: (2023)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
por: Chen, Yudi, et al.
Publicado: (2021)

274 Vasculitic Urticaria Treated with Omalizumab. Case Report
por: Ramírez Del Pozo, María Elena, et al.
Publicado: (2012)

281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
por: Correa, Jorge Vargas
Publicado: (2012)

A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real‐world study in Belgium
por: Lapeere, H., et al.
Publicado: (2019)

Urticaria and mimickers of urticaria
por: Fok, Jie Shen, et al.
Publicado: (2023)

Chronic Urticaria: The Need for Improved Definition
por: Gómez, R. Maximiliano, et al.
Publicado: (2022)

Therapeutic efficacy of omalizumab in children with moderate-to-severe allergic asthma combined with chronic sinusitis
por: Chong, Weikun, et al.
Publicado: (2023)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

Comorbidities of Chronic Urticaria: A glimpse into a complex relationship
por: Papapostolou, Niki, et al.
Publicado: (2022)

Urticaria in Pregnancy and Lactation
por: Kocatürk, Emek, et al.
Publicado: (2022)

Editorial: The complexity of urticaria
por: Makris, Michael, et al.
Publicado: (2023)

Cold-induced urticaria after black ant bite anaphylaxis
por: Mohamed, Sara, et al.
Publicado: (2023)

Expert consensus on the use of omalizumab in chronic urticaria in China()
por: Zhao, Zuotao, et al.
Publicado: (2021)

The many faces of pediatric urticaria
por: Sekerel, Bulent Enis, et al.
Publicado: (2023)

Penicillin Allergy and Perioperative Anaphylaxis
por: Ramsey, Allison
Publicado: (2022)

Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic
por: Haddad, Isabelle, et al.
Publicado: (2022)

The impact of home treatment and self-administration of omalizumab on chronic urticaria
por: Wiuff, Anne Christine, et al.
Publicado: (2022)

Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking Countries
por: Altrichter, Sabine, et al.
Publicado: (2022)

Basophil Activation Test as a Biomarker for Taxanes Anaphylaxis
por: De Campos, Lucila, et al.
Publicado: (2022)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

COVID-19 Vaccine Anaphylaxis: Current Evidence and Future Approaches
por: Laisuan, Wannada
Publicado: (2021)

275 Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome: A Case Report
por: Varricchi, Gilda, et al.
Publicado: (2012)

Long-Term Experience with Anaphylaxis and Desensitization to Alglucosidase Alfa in Pompe Disease
por: Ertoy Karagol, Hacer Ilbilge, et al.
Publicado: (2023)

Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
por: Comberiati, Pasquale, et al.
Publicado: (2019)

Case report: Severe chronic spontaneous urticaria successfully treated with omalizumab and dupilumab
por: Puxkandl, Viktoria, et al.
Publicado: (2023)

T cell activity in successful treatment of chronic urticaria with omalizumab
por: Sánchez-Machín, Inmaculada, et al.
Publicado: (2011)

Omalizumab therapy in three patients with chronic autoimmune urticaria
por: Al-Ahmad, Mona
Publicado: (2010)

Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria
por: Nam, Young-Hee, et al.
Publicado: (2012)

Effects of omalizumab on chronic urticaria not responding to recommended therapy
por: Hébert, Jacques, et al.
Publicado: (2012)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

Anaphylaxis after consumption of wasp larvae in Reunion Island: a case report
por: Maillot, Adrien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_in9m07i6ht828uvmte2u6igua2